Abstract
This chapter, divided into three sections, discusses important developments in microsphere technology for parenteral drug delivery. In the first section, microsphere systems are briefly described and polymers including both natural and synthetic polymers used in microsphere technology are reviewed. In the second section, various conventional microsphere fabrication methods as well as recent advances in microsphere preparation methods are discussed. Specific examples of microsphere applications, including microspheres for small molecules, protein therapeutics and vaccines are provided. In the final section, some of the challenges associated with developing microsphere products and means to overcome these challenges are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Polymeric systems for Âcontrolled drug release. Chem Rev 99(11):3181–3198. doi:10.1021/cr940351u
Jain R, Shah NH, Malick AW, Rhodes CT (1998) Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. Drug Dev Ind Pharm 24(8):703–727
Burgess DJ, Davis SS, Tomlinson E (1987) Potential use of albumin microspheres as a drug delivery system.I. Preparation and in vitro release of steroids. Int J Pharm 39(1–2):129–136. doi:10.1016/0378-5173(87)90207-9
Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RR (2005) Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS Pharm Sci Tech 6(1):E65–E73
Panduranga Rao K (1996) Recent developments for collagen-based materials for medical applications and drug delivery systems. J Biomater Sci Polym Ed 7(7):623–645
Nagai N, Kumasaka N, Kawashima T, Kaji H, Nishizawa M, Abe T (2010) Preparation and characterization of collagen microspheres for sustained release of VEGF. J Mater Sci Mater Med 21:1891–1898
Baba S, Matsumoto N, Kaneshita Y, Inami K, Morikuni H, Kawazoe T (2008) Efficacy of bone regeneration using collagen microspheres as scaffold. J Osaka Dent Univ 42(1):9–15
Dinarvand R, Mahmoodi S, Farboud E, Salehi M, Atyabi F (2005) Preparation of gelatin microspheres containing lactic acid – effect of cross-linking on drug release. Acta Pharm 55:57–67
Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS (2002) Preparation and characterization of Âchitosan microparticles intended for controlled drug delivery. Int J Pharm 249(1–2):165–174. doi:10.1016/s0378-5173(02)00487-8
Dhawan S, Singla AK (2003) Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation. Biotech Histochem 78(5):243–254
Ly L, Ls W (1998) Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique. J Microencapsul 15(3):319–333
He P, Davis SS, Illum L (1999) Chitosan microspheres prepared by spray drying. Int J Pharm 187(1):53–65. doi:10.1016/s0378-5173(99)00125-8
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro Âtechnologies for delivering macromolecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives. J Controlled Release 125(3):193–209. doi:10.1016/j.jconrel.2007.09.013
Capan Y, Jiang G, Giovagnoli S, Na K-H, Deluca PP (2003) Preparation and Characterization of Poly(D, L-lactide-co-glycolide) Microspheres for Controlled Release of Human Growth Hormone. AAPS Pharm Sci Tech 4(2)
Wischke C, Schwendeman SP (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 364(2):298–327. doi:10.1016/j.ijpharm.2008.04.042
Zhou S, Liao X, Li X, Deng X, Li H (2003) Poly–lactide-co-poly(ethylene glycol) Âmicrospheres as potential vaccine delivery systems. J Controlled Release 86(2–3):195–205. doi:10.1016/s0168-3659(02)00423-6
Nojehdehian H, Moztarzadeh F, Baharvand H, Nazarian H, Tahriri M (2009) Preparation and surface characterization of poly-l-lysine-coated PLGA microsphere scaffolds containing Âretinoic acid for nerve tissue engineering: In vitro study. Colloids Surf B: Biointerfaces 73(1):23–29. doi:10.1016/j.colsurfb.2009.04.029
Zolnik BS, Burgess DJ (2007) Effect of acidic pH on PLGA microsphere degradation and release. J Controlled Release 122(3):338–344. doi:10.1016/j.jconrel.2007.05.034
Zolnik BS, Leary PE, Burgess DJ (2006) Elevated temperature accelerated release testing of PLGA microspheres. J Controlled Release 112(3):293–300. doi:10.1016/j.jconrel.2006.02.015
Domb AJ, Langer R (1987) Polyanhydrides. I. Preparation of high molecular weight polyanhydrides. J Polym Sci Part A: Polym Chem 25(12):3373–3386
Tamada J, Langer R (1992) The development of polyanhydrides for drug delivery Âapplications. J Biomater Sci Polym Ed 3(4):315–353
Manoj M, Xiaodong X, DA J (1990) Polyanhydrides. V. Branched polyanhydrides. Biomaterials 11(9):690–694
Gˆpferich A, Tessmar J (2002) Polyanhydride degradation and erosion. Adv Drug Deliv Rev 54(7):911–931. doi:10.1016/s0169-409x(02)00051-0
Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW (2004) Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Controlled Release 94(1):129–141. doi:10.1016/j.jconrel.2003.09.011
Park E-S, Maniar M, Shah J (1996) Water uptake in to polyanhydride devices: kinetics of uptake and effects of model compounds incorporated, and device geometry on water uptake. J Controlled Release 40(1–2):55–65. doi:10.1016/0168-3659(95)00143-3
Lazko J, Popineau Y, Legrand J (2004) Soy glycinin microcapsules by simple coacervation method. Colloids Surf B: Biointerfaces 37(1–2):1–8. doi:10.1016/j.colsurfb.2004.06.004
Wei G, Knoch A, Laicher A, Stanislaus F, Daniels R (1995) Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP) II. Microencapsulation of ibuprofen. Int J Pharm 124(1):97–105. doi:10.1016/0378-5173(95)00085-w
Wei G, Knoch A, Laicher A, Stanislaus F, Daniels R (1995) Simple coacervation of hydroxypropyl methylcellulose phthalate (HPMCP) I. Temperature and pH dependency of coacervate formation. Int J Pharm 124(1):87–96. doi:10.1016/0378-5173(95)00084-v
Bachtsi AR, Kiparissides C (1996) Synthesis and release studies of oil-containing poly(vinyl alcohol) microcapsules prepared by coacervation. J Controlled Release 38(1):49–58. doi:10.1016/0168-3659(95)00099-2
Nihant N, Grandfils C, JÈrÙme R, TeyssiÈ P (1995) Microencapsulation by coacervation of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and Âencapsulation. J Controlled Release 35(2–3):117–125. doi:10.1016/0168-3659(95)00026-5
Singh ON, Burgess DJ (1989) Characterization of albumin-alginic acid complex coacervation. J Pharm Pharmacol 41(10):670–673
Burgess DJ, Carless JE (1984) Microelectrophoretic studies of gelatin and acacia for the Âpredic-tion of complex coacervation. J Colloid Int Sci 98(1):1–8. doi:10.1016/0021-9797(84)90472-7
Rattes ALR, Oliveira WP (2007) Spray drying conditions and encapsulating composition effects on formation and properties of sodium diclofenac microparticles. Powder Technol 171:7–14
Ponsart S, Burgess DJ (1996) Microencapsulation of [beta]-glucuronidase by spray-drying. Eur J Pharm Sci 4(Supplement 1):S76–S76
Li W-I, Anderson KW, Deluca PP (1995) Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. J Controlled Release 37(3):187–198. doi:10.1016/0168-3659(95)00077-1
Freitas S, Merkle HP, Gander B (2005) Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Controlled Release 102(2):313–332. doi:10.1016/j.jconrel.2004.10.015
Li M, Rouaud O, Poncelet D (2008) Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharmaceutics 363(1–2):26–39. doi:10.1016/j.ijpharm.2008.07.018
Rawat A, Burgess DJ (2010) Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics. Int J Pharm 394(1–2):99–105. doi:10.1016/j.ijpharm.2010.05.013
Yuan Y, Chesnutt BM, Utturkar G, Haggard WO, Yang Y, Ong JL, Bumgardner JD (2007) The effect of cross-linking of chitosan microspheres with genipin on protein release. Carbohydr Polym 68(3):561–567. doi:10.1016/j.carbpol.2006.10.023
Saleh AM, El-Khordagui LK, Robb DA, Florence AT (1989) Effect of some drugs and additives on the cross-linking of bovine serum albumin by glutaraldehyde. Int J Pharm 57(3):205–210. doi:10.1016/0378-5173(89)90208-1
Chen X, Chen Z, Lu G, Bu W, Yang B (2003) Measuring the swelling behavior of polymer microspheres with different cross-linking densities and the medium-dependent color changes of the resulting latex crystal films. J Colloid Interface Sci 264(1):266–270. doi:10.1016/s0021-9797(03)00485-5
Lim F, Sun A (1980) Microencapsulated islets as bioartifical endocrine pancreas. Science 210(4472):908–910
Alexandridou S, Kiparissides C, Mange F, Foissy A (2001) Surface characterization of oil-containing polyterephthalamide microcapsules prepared by interfacial polymerization. J Microencapsul 18(6):767–781
Lee TH, Wang J, Wang C-H (2002) Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies. J Controlled Release 83(3):437–452. doi:10.1016/s0168-3659(02)00235-3
Mathiowitz E, Langer RS (1989) Preparation of multiwall polymeric microcapsules. USA Patent
Rahman NA, Mathiowitz E (2004) Localization of bovine serum albumin in double-walled microspheres. J Controlled Release 94(1):163–175
Pekarek K, Jacob J, Mathlowitz E (1994) Double-walled polymer microspheres for controlled drug release. Nature 367(6460):258–260
Yang Y-Y, Shi M, Goh S-H, Moochhala SM, Ng S, Heller J (2003) POE/PLGA composite microspheres: formation and in vitro behavior of double walled microspheres. J Controlled Release 88(2):201–213. doi:10.1016/s0168-3659(02)00491-1
Reinhold SE (2009) Self-healing polymers microcapsulate biomacromolecules without organic solvents. The University of Michigan
Yeo Y, Chen AU, Basaran OA, Park K (2004) Solvent exchange method: a novel microencapsulation technique using dual microdispensers. Pharm Res 21(8):1419–1427. doi:10.1023/B:PHAM.0000036916.96307.d8
Xu Q, Hashimoto M, Dang TT, Hoare T, Kohane DS, Whitesides GM, Langer R, Anderson DG (2009) Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 5(13):1575–1581. doi:10.1002/smll.200801855
Porta GD, Adami R, Del Gaudio P, Prota L, Aquino R (2010) Reverchon E Albumin/gentamicin microspheres produced by supercritical assisted atomization: Optimization of size, drug loading and release. J Pharm Sci 99(11):4720–4729. doi:10.1002/jps.22173
Blanco-PrÌeto MJ, Lecaroz C, Renedo MJ, Kunkova J, Gamazo C (2002) In vitro evaluation of gentamicin released from microparticles. Int J Pharm 242(1–2):203–206. doi:10.1016/s0378-5173(02)00158-8
Kohane DS, Smith SE, Louis DN, Colombo G, Ghoroghchian P, Hunfeld NGM, Berde CB, Langer R (2003) Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 104(1–2):415–421. doi:10.1016/s0304-3959(03)00049-6
Wang C, Adrianus GN, Sheng N, Toh S, Gong Y, Wang D-A (2009) In vitro performance of an injectable hydrogel/microsphere based immunocyte delivery system for localised anti-tumour activity. Biomaterials 30(36):6986–6995. doi:10.1016/j.biomaterials.2009.09.006
Hickey T, Kreutzer D, Burgess DJ, Moussy F (2002) Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 23(7):1649–1656. doi:10.1016/s0142-9612(01)00291-5
Burgess DJ, Davis SS (1988) Potential use of albumin microspheres as a drug delivery system: II. In vivo deposition and release of steroids. Int J Pharm 46(1–2):69–76. doi:10.1016/0378-5173(88)90011-7
Liggins RT, Cruz T, Min W, Liang L, Hunter WL, Burt HM (2004) Intra-articular treatment of arthritis with microsphere formulations of paclitaxel biocompatibility and efficacy determinations in rabbits. Inflam Res 53(8):363–372
Pandey R, Khuller G (2004) Chemotherapeutic potential of alginate-chitosan microspheresas anti-tubercular drug carriers. J Antimicrob Chemother 53(4):635–640
Lee KY, Yuk SH (2007) Polymeric protein delivery systems. Prog Polym Sci 32(7):669–697. doi:10.1016/j.progpolymsci.2007.04.001
Organization WH (2011) World Health Organization
Hinds KD, Campbell KM, Holland KM, Lewis DH, PichÈ CA, Schmidt PG (2005) PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis. J Controlled Release 104(3):447–460
Lee J, Tan CY, Lee S-K, Kim Y-H, Lee KY (2009) Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Controlled Release 137(3):196–202
Fujii T, Yonemitsu Y, Onimaru M, Inoue M, Hasegawa M, Kuwano H, Sueishi K (2008) VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis. Atherosclerosis 200(1):51–57. doi:10.1016/j.atherosclerosis.2007.12.012
Kim T, Burgess DJ (2002) Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol 54(7):897–905
Patil SD, Papadmitrakopoulos F, Burgess DJ (2007) Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Controlled Release 117(1):68–79. doi:10.1016/j.jconrel.2006.10.013
Jiang W, Gupta RK, Deshpande MC, Schwendeman SP (2005) Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57(3):391–410. doi:10.1016/j.addr.2004.09.003
Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM (1991) Biodegradable microspheres as a vaccine delivery system. Mol Immunol 28(3):287–294. doi:10.1016/0161-5890(91)90076-v
Lee HK, Park JH, Kwon KC (1997) Double-walled microparticles for single shot vaccine. J Controlled Release 44(2–3):283–293. doi:10.1016/s0168-3659(96)01534-9
Jang J-H, Shea LD (2006) Intramuscular delivery of DNA releasing microspheres: Microsphere properties and transgene expression. J Controlled Release 112(1):120–128
Wang D, Robinson DR, Kwon GS, Samuel J (1999) Encapsulation of plasmid DNA in biodegradable poly(,-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Controlled Release 57(1):9–18. doi:10.1016/s0168-3659(98)00099-6
Castellanos IJ, Cruz G, Crespo R, Griebenow K (2002) Encapsulation-induced aggregation and loss in activity of [gamma]-chymotrypsin and their prevention. J Controlled Release 81(3):307–319. doi:10.1016/s0168-3659(02)00073-1
Sah H (1999) Protein behavior at the water/methylene chloride interface. J Pharm Sci 88(2):1320–1325
Maa Y-F, Hsu CC (1997) Protein denaturation by combined effect of shear and air-liquid interface. Biotechnol Bioeng 54(6):503–512
Oliva A, SantoveÒa A, FariÒa J, LlabrÈs M (2003) Effect of high shear rate on stability of proteins: kinetic study. J Pharm Biomed Anal 33(2):145–155. doi:10.1016/s0731-7085(03)00223-1
Sah H, Bahl Y (2005) Effects of aqueous phase composition upon protein destabilization at water/organic solvent interface. J Controlled Release 106(1–2):51–61. doi:10.1016/j.jconrel.2005.04.020
Liu WR, Lanter R, Klibanov AM (1991) Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol Bioeng 37(2):177–184
Arakawa T, Timasheff SN (1982) Stabilization of protein structure by sugars. Biochemistry 21(25):6536–6544
Cho M, Sah H (2005) Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process. J Microencapsul 22:1
Allison S (2008) Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv 5(6):615–628
Jeyanthi R, Thanoo BC, Metha RC, Deluca PP (1996) Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J Controlled Release 38(2–3):235–244. doi:10.1016/0168-3659(95)00125-5
Sandor M, Enscore D, Weston P, Mathiowitz E (2001) Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Controlled Release 76(3):297–311. doi:10.1016/s0168-3659(01)00446-1
Wang J, Wang BM, Schwendeman SP (2002) Characterization of the initial burst release of a model peptide from poly(-lactide-co-glycolide) microspheres. J Controlled Release 82(2–3):289–307. doi:10.1016/s0168-3659(02)00137-2
Huang X, Brazel CS (2001) On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Controlled Release 73(2–3):121–136. doi:10.1016/s0168-3659(01)00248-6
MallardÈ D, Boutignon F, Moine F, BarrÈ E, David S, Touchet H, Ferruti P, Deghenghi R (2003) PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release. Int J Pharm 261(1–2):69–80. doi:10.1016/s0378-5173(03)00272-2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Controlled Release Society
About this chapter
Cite this chapter
Wang, Y., Burgess, D.J. (2012). Microsphere Technologies. In: Wright, J., Burgess, D. (eds) Long Acting Injections and Implants. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0554-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0554-2_10
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0553-5
Online ISBN: 978-1-4614-0554-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)